Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Centa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2022
Targeting Alternative Splicing for Therapeutic InterventionsJessica L Centa, Michelle L Hastings
Nucleic Acids Research|November 8, 2025
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Jessica L Centa, et al.
Molecular Therapy. Nucleic Acids|June 26, 2023
Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approachJessica L Centa, Matthew P Stratton, Melissa A Pratt, et al.
Nature Medicine|July 29, 2020
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten diseaseJessica L Centa, Francine M Jodelka, Anthony J Hinrich, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseMatthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Nucleic Acids Research|November 5, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseMatthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|July 27, 2022
Targeting Alternative Splicing for Therapeutic InterventionsJessica L Centa, Michelle L Hastings
Nucleic Acids Research|November 8, 2025
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammationRoni Klein, Janset Onyuru, Jessica L Centa, et al.
Molecular Therapy. Nucleic Acids|June 26, 2023
Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approachJessica L Centa, Matthew P Stratton, Melissa A Pratt, et al.
Nature Medicine|July 29, 2020
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten diseaseJessica L Centa, Francine M Jodelka, Anthony J Hinrich, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseMatthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Nucleic Acids Research|November 5, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseMatthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Pageof 1